COMPOUNDS AS PD1/PD-L1 INHIBITORS AND METHODS THEREOF

The present invention relates in general, to the field of pharmaceutical compounds, more particularly to the compounds of Formula (I) which acts as inhibitors for PD1/PD-L1 interaction. The present invention further relates to a method of preparation of compounds of Formula (I). The present inventio...

Full description

Saved in:
Bibliographic Details
Main Authors SIVANANDHAN, Dhanalakshmi, SADHU, Naveen, MOHD, Zainuddin, RAJAGOPAL, Sridharan
Format Patent
LanguageEnglish
French
Published 27.10.2022
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates in general, to the field of pharmaceutical compounds, more particularly to the compounds of Formula (I) which acts as inhibitors for PD1/PD-L1 interaction. The present invention further relates to a method of preparation of compounds of Formula (I). The present invention also relates to a composition of compounds of Formula (I). La présente invention concerne en général le domaine des composés pharmaceutiques, plus particulièrement les composés de formule (I) qui agissent en tant qu'inhibiteurs de l'interaction PD1/PD-L1. La présente invention concerne en outre un procédé de préparation de composés de Formule (I). La présente invention concerne également une composition de composés de formule (I).
Bibliography:Application Number: WO2022IN50381